Neuroblastoma: developmental biology, cancer genomics and immunotherapy
NKV Cheung, MA Dyer - Nature Reviews Cancer, 2013 - nature.com
Neuroblastoma is a solid tumour that arises from the developing sympathetic nervous
system. Over the past decade, our understanding of this disease has advanced …
system. Over the past decade, our understanding of this disease has advanced …
The myc oncogene: MarvelouslY complex
SK Oster, CSW Ho, EL Soucie, LZ Penn - 2002 - Elsevier
The activated product of the myc oncogene deregulates both cell growth and death check
points and, in a permissive environment, rapidly accelerates the affected clone through the …
points and, in a permissive environment, rapidly accelerates the affected clone through the …
A mechanistic classification of clinical phenotypes in neuroblastoma
S Ackermann, M Cartolano, B Hero, A Welte, Y Kahlert… - Science, 2018 - science.org
Neuroblastoma is a pediatric tumor of the sympathetic nervous system. Its clinical course
ranges from spontaneous tumor regression to fatal progression. To investigate the molecular …
ranges from spontaneous tumor regression to fatal progression. To investigate the molecular …
EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis
A Mittal, MS Pate, RC Wylie… - International …, 2004 - spandidos-publications.com
Telomerase is elevated in> 90% of breast carcinomas and therefore has received much
attention as a target for breast cancer therapy and cancer diagnostic research. Dietary …
attention as a target for breast cancer therapy and cancer diagnostic research. Dietary …
The biologic basis for neuroblastoma heterogeneity and risk stratification
JM Maris - Current opinion in pediatrics, 2005 - journals.lww.com
Neuroblastoma remains a significant challenge as high-risk patients are treated with
intensive multimodal therapies but cure rates remain suboptimal. There is remarkable …
intensive multimodal therapies but cure rates remain suboptimal. There is remarkable …
Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma
R Gertler, R Rosenberg, D Stricker… - Journal of clinical …, 2004 - ascopubs.org
Purpose Maintenance of telomeres through reactivation of telomerase is a prerequisite for
tumors to preserve their ability to proliferate. The purpose of this study was to evaluate …
tumors to preserve their ability to proliferate. The purpose of this study was to evaluate …
Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas
C Scheel, KL Schaefer, A Jauch, M Keller, D Wai… - Oncogene, 2001 - nature.com
Telomere maintenance is regarded as a key mechanism in overcoming cellular senescence
in tumor cells and in most cases is achieved by the activation of telomerase. However there …
in tumor cells and in most cases is achieved by the activation of telomerase. However there …
Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo …
M Kammori, N Izumiyama… - International …, 2005 - spandidos-publications.com
Human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase, is
very closely associated with telomerase activity. Telomerase has been implicated in cellular …
very closely associated with telomerase activity. Telomerase has been implicated in cellular …
Telomerase as a prognostic marker in breast cancer: high‐throughput tissue microarray analysis of hTERT and hTR
C Poremba, B Heine, R Diallo… - The Journal of …, 2002 - Wiley Online Library
Telomerase activity (TA) has been shown to correlate with poor clinical outcome in various
tumour entities, indicating that tumours expressing this enzyme may be more aggressive …
tumour entities, indicating that tumours expressing this enzyme may be more aggressive …
Telomerase is a prognostic marker of poor outcome and a therapeutic target in neuroblastoma
A Roderwieser, F Sand, E Walter, J Fischer… - JCO Precision …, 2019 - ascopubs.org
PURPOSE Telomere maintenance is a hallmark of high-risk neuroblastoma; however, the
contribution of telomerase and alternative lengthening of telomeres (ALT) to clinical …
contribution of telomerase and alternative lengthening of telomeres (ALT) to clinical …